Sublingual immunotherapy with house dust extract for house dust-mite allergic rhinitis in children

Allergology International

Volumn 59, Issue 4, 2010, Pages 381-388

  Yonekura, Syuji ^a   Okamoto, Yoshitaka ^a   Sakurai, Daiju ^a   Horiguchi, Shigetoshi ^a   Hanazawa, Toyoyuki ^a   Nakano, Atsuko ^b   Kudou, Fumiyo ^c   Nakamaru, Yuji ^d   Honda, Kohei ^e   Hoshioka, Akira ^f   Shimojo, Naoki ^g   Kohno, Yoichi ^g  

^a Head and Neck Surgery

^b CHIBA UNIVERSITY   (Japan)

^c Division of Otorhinolaryngology

^d CHIBA CHILDREN'S HOSPITAL   (Japan)

^e CHIBA PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

^f HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g AKITA UNIVERSITY   (Japan)

Author keywords

Children; Double blind; House dust extract; House dust mite allergic rhinitis; Placebo controlled trial; Sublingual immunotherapy

Indexed keywords

HOUSE DUST ALLERGEN; PLACEBO;

ADOLESCENT; ALLERGIC RHINITIS; ARTICLE; BITTER TASTE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DERMATOPHAGOIDES; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HOUSE DUST; HOUSE DUST ALLERGY; HUMAN; IMMUNOTHERAPY; JAPAN; MALE; NOSE CONGESTION; PRIORITY JOURNAL; RHINORRHEA; SCHOOL CHILD; SCORING SYSTEM; SIDE EFFECT; SNEEZING; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

EID: 78650812534     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.10-OA-0200     Document Type: Article

References (25)

1. Bousquet J, Khaltaev N, Cruz A.A et al, andWorld Health Organization; GA (2) LEN; Allergen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update. Allergy 2008; 63 (Suppl 86):8-160.
2. Asher MI, Montefort S, Bjorksten B et al, and ISAAC Phase Three Study Group. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006;368:733-43.
3. Wahn U. What drives allergic march? Allergy 2000;55: 591-9.
4. Selnes A, Nystad W, Bolle R, Lund E. Diverging prevalence trends of atopic disorders in Norwegian children. Results from three cross-sectional studies. Allergy 2005; 60:894-9.
5. Gelfand EW. Pediatric allergic rhinitis: factors affecting treatment choice. Ear Nose Throat J 2005;84:163-8.
6. Horst M, Hejjaoui A, Horst V, Michel FB, Bousquet J. Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract. J Allergy Clin Immunol 1990;85:460-72.
7. Corrado OJ, Pastorello E, Ollier S. A double-blind study of hyposensitization with an alginate conjugated extract of D. pteronyssinus (Conjuvac) in patients with perennial rhinitis. 1. Clinical aspects. Allergy 1989;44:108-15.
8. D'Souza MF, Pepys J, Wells ID et al. Hyposensitization with Dermatophagoides pteronyssinus in house dust allergy: a controlled study of clinical and immunological effects. Clin Allergy 1973;3:177-93.
9. Ewan PW, Alexander MM, Snape C, Ind PW, Agrell B, Dreborg S. Effective hyposensitization in allergic rhinitis using a potent partially purified extract of house dust mite. Clin Allergy 1988;18:501-8.
10. Pichler CE, Marquardsen A, Sparholt S et al. Specific immunotherapy with Dermatophagoides pteronyssinus and D. farinae results in decreased bronchial hyperreactivity. Allergy 1997;52:274-83.
11. Warner JO, Price JF, Soothill JF, Hey EN. Controlled trial of hyposensitisation to Dermatophagoides pteronyssinus in children with asthma. Lancet 1978;2:912-5.
12. Lockey RF, Nicoara-Kasti GL, Theodoropoulos DS, Bukantz SC. Systemic reactions and fatalities associated with allergen immunotherapy. Ann Allergy Asthma Immunol 2001;87 (Suppl 1):47-55.
13. Bahceciler NN, I-ik U, Barlan IB, Ba-aran MM. Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study. PediatrPulmonol 2001;32:49-55.
14. Ippoliti F, De Santis W, Volterrani A et al. Immunomodulation during sublingual therapy in allergic children. Pediatr Allergy Immunol 2003;14:216-21.
15. Tari MG, Mancino M, Monti G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study. Allergol Immunopathol (Madr) 1990;18:277-84.
16. Hirsch T, Sahn M, Leupold W. Double-blind placebocontrolled study of sublingual immunotherapy with house dust mite extract (D.pt.) in children. Pediar Allergy Immunol 1997;8:21-7.
17. Ukai K, Amesara R, Masuda S et al. [The evaluation of hyposensitization with house dust in patients with nasal allergy to house dust-mite]. Arerugi 1994;43:16-21(in Japanese).
18. Horiguchi S, Okamoto Y, Yonekura S et al. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis. Int Arch Allergy Immunol 2008;146:76-84.
19. Okuda M. Epidemiology of Japanese cedar pollinosis throughout Japan. Ann Allergy Asthma Immunol 2003;91: 288-96.
20. Okuda M. Grading the severity of allergic rhinitis for treatment strategy and drug study purposes. Curr Allergy Asthma Rep 2001;1:235-41.
21. [Practical Guideline for the Management of Allergic Rhinitis in Japan-Perennial Rhinitis and Pollinosis], 2009 (6th) edn. Tokyo: Life Science, 2008 (in Japanese).
22. Roder E, Berger MY, de Groot H, van Wijk RG. Immunotherapy in children and adolescents with allergic rhinoconjunctivitis: a systematic review. Pediatr Allergy Immunol 2008;19:197-207.
23. Penagos M, Compalati E, Tarantini F et al. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a metaanalysis of randomized, placebo-controlled, double-blind trials. Ann Allergy Asthma Immunol 2006;97:141-8.
24. Wilson DR, Lima MT, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and metaanalysis. Allergy 2005;60:4-12.
25. Calamita Z, Saconato H, Pela AB, Atallah AN. Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method. Allergy 2006;61:1162-72.